Stay updated on BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T19:23:10.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page shows a new revision label, 'v3.4.2', replacing 'v3.4.1'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:47:01.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; this is a minor metadata page change and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:17:04.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Version updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.0%
    Check dated 2026-01-15T04:31:18.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page now lists study locations by state (Arkansas, California, Florida, Kentucky, Louisiana, Missouri, Nevada, New Jersey, Ohio, South Carolina, Texas) and shows an updated revision tag (v3.3.3). The HHS Vulnerability Disclosure link was removed.
    Difference
    1%
    Check dated 2025-12-24T11:52:22.000Z thumbnail image
  8. Check
    108 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T14:50:46.000Z thumbnail image

Stay in the know with updates to BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.